LumiraDx Ltd
LONDON, X0 · Founded 2016 · CIK 0001685428 · Medtech · Acquired
Microfluidic immunofluorescence assay device for rapid detection of viral antigen from nasal swabs
diagnostics.roche.com →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- $682M
- 9 Form D · Dec 2020
- 70 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 25
- 5 granted · 20 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓201620172018201920202021
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $42,625,000 | |
| Private capital raised | Form D · SEC | $613,156 | |
| Private capital raised | Form D · SEC | $270,000,000 | |
| Private capital raised | Form D · SEC | $76,675,000 | |
| Private capital raised | Form D · SEC | $75,155,586 | |
| Private capital raised | Form D · SEC | $74,000,000 | |
| Private capital raised | Form D · SEC | $52,550,000 | |
| Private capital raised | Form D · SEC | $164,000,000 |
Form D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 675 | APPLIED PARTICLE TECHNOLOGY, LLC | — | — |
| 676 | ALAN PENN AND ASSOCIATES, INC. | — | — |
| 677 | INTEGRATED SENSING SYSTEMS, INC. (ISSYS) | — | — |
| 678 | LumiraDx Ltd | — | $682M |
| 679 | ADVANCED VASCULAR THERAPIES, INC. | — | — |
| 680 | STARK STREET MATERIALS COMPANY | — | — |
| 681 | BIOGRAFT, INC. | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Veronique AmeyeExecutive Officer
- Donald BerwickDirector
- Troy BrennanDirector
- Troyen BrennanDirector
- Gerald ChanDirector
- Lu HuangDirector
- Lurene JosephDirector
- Bruce KeoghDirector
- Dorian LeBlancExecutive Officer
- Nigel LindnerExecutive Officer
- Jerry McAleerDirector · Executive Officer
- Sumit NagpalExecutive Officer
- George NebleDirector
- Tom QuinlanExecutive Officer
- Peter ScheuExecutive Officer
- David ScottDirector · Executive Officer
- Amit ThakkerDirector
- Suresh VaziraniDirector
- David WaltonExecutive Officer
- Peter WelchExecutive Officer
- Ron ZwanzigerDirector · Executive Officer
Patents
- Segmented Fluidic Mixingapplication
- Improvements In Or Relating To Nicking Enzymesgranted
- A Magnetic Assembly For Use In A Device For Conducting Assaysgranted
- Saturation Binding Ratiometric Assaygranted
- Microfluidic Devicesapplication
- Sample Processing Devices And Methodsapplication
- Fluid Controlapplication
- Fluid Control In Microfluidic Devicesapplication
- Fluid Controlgranted
- Improvements In Or Relating To Digestion Of Reaction Productsapplication
- Amplification Of Nucleic Acidsapplication
- System For Detection Of A Target In A Liquid Sampleapplication
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.